Autonomous biomedical research with an artificial intelligence agent.
An autonomous AI agent successfully diagnosed rare diseases and found drug repurposing candidates by reasoning through scientific literature alone.
Biomni is a general-purpose AI agent that mines thousands of publications to build a unified action space spanning 25 biomedical domains, then autonomously composes and executes research workflows using LLM reasoning, database retrieval, and code execution. Published in Science by teams from Stanford, Arc Institute, and Genentech, it represents a milestone in autonomous scientific discovery, performing rare-disease diagnosis and drug repurposing among its benchmark tasks without domain-specific fine-tuning.
What the study was
- Study design
- computational_benchmarking
- Category
- ai_ml_diagnostics
- Maturity
- Validated
- Journal
- Science
Why it surfaced
Science publication from Snyder/Regev/Leskovec labs—landmark AI for biomedical research automation; explicit rare-disease diagnosis capability; clinical applicability capped at 1 (research agent, not bedside tool); flagged as SENTINEL because it spans and accelerates all watchlist domains.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.